BABA vs BCAX · P/E 20, rev $137.30B vs $1.51B cap
Alibaba Group Holding Ltd (BABA) versus Bicara Therapeutics Inc. Common Stock (BCAX) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
BCAX does not have a complete income-statement cache yet.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. BCAX currently screens at market cap $1.51B.
Not investment advice. Open the BABA and BCAX stock pages for the full models.
Not investment advice.